Mar, Diane
Valenzuela, Antonia
Stevens, Kathryn J.
Chung, Lorinda
Fairchild, Robert M.
Article History
Received: 4 February 2021
Revised: 26 February 2021
Accepted: 12 March 2021
First Online: 23 March 2021
Declarations
: The manuscript does not contain clinical studies or patient data.
: Dr. Lorinda Chung has received consulting fees from Eicos, Mitsubishi Tanabe, and Boehringer Ingelheim. Dr. Lorinda Chung receives funding from the Scleroderma Research Foundation. Dr. Antonia Valenzuela acknowledges the support from Development (ANID) Grant Fondecyt de Iniciación en Investigación Nº 11190426. Dr. Robert Fairchild recieves support from Boehringer Ingelheim. The other authors declare they have no conflict of interest related to this manuscript.